Cariban 10 mg/10 mg, gélule à libération modifiée

7680676700010 CH-67670 Kapseln
Cariban 10 mg/10 mg, gélule à libération modifiée
Cariban 10 mg/10 mg, gélule à libération modifiée
Cariban 10 mg/10 mg, gélule à libération modifiée
1 / 3
google

Article details

Package size
24
Selling units
24
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/07/2023
Patient information leaflet
Français
07/07/2023
Patient information leaflet
Italien
07/07/2023
Summary of Product Characteristics
Allemand
07/07/2023
Summary of Product Characteristics
Français
07/07/2023
Summary of Product Characteristics
Italien
07/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance WIZUS
(N/A)
7.0 MG Substance Wirkstoff (Principe actif)
(N/A)
10.0 MG Substance WIZUS
(N/A)
8.2 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 34.90
Specialties list
Yes
Generic
No
SL addition date: 01/02/2021

Authorization holder

EFFIK SA

1260 Nyon

Authorization information

Swissmedic authorization number
67670
Drug name
Cariban, gélule à libération modifiée
Galenic form
KAHA
ATC Code
R06AA59
Authorization status
Z
Dispensing category
B
First authorization
12/11/2020
Authorization expiration date
31/12/9999
IT Number
01.09.0.
Domain
Human medicine

Package details

Description (FR)
CARIBAN caps ret 10mg/10mg 24 pce
Description (DE)
CARIBAN Ret Kaps 10mg/10mg 24 Stk
Market launch
12/11/2020
Narcotic (BTM)
No

Other package sizes (1)

CARIBAN caps ret 10mg/10mg 48 pce
48 KAP
GTIN: 7680676700027
View